Patents Examined by Lindsey G. Wehrheim
-
Patent number: 12380983Abstract: The disclosure describes techniques for associating therapy adjustments with posture states using a timer. The techniques may include detecting a patient adjustment to electrical stimulation therapy delivered to the patient, sensing a posture state of the patient, and associating the detected adjustment with the sensed posture state if the sensed posture state is sensed within a first period following the detection of the adjustment and if the sensed posture state does not change during a second period following the sensing of the sensed posture state.Type: GrantFiled: May 10, 2021Date of Patent: August 5, 2025Assignee: Medtronic, Inc.Inventor: Dennis M. Skelton
-
Patent number: 12377272Abstract: The present disclosure is directed to a system and method for selectively and reversibly modulating targeted neural and non-neural tissue of a nervous system for the treatment of pain. An electrical stimulation is delivered to the treatment site that selectively and reversibly modulates the targeted neural- and non-neural tissue of the nervous structure, inhibiting pain while preserving other sensory and motor function, and proprioception.Type: GrantFiled: December 17, 2021Date of Patent: August 5, 2025Assignee: Avent, Inc.Inventors: Eric A. Schepis, David M. Page, Phillip A. Schorr, Shyamy R. Sastry, Leah Roldan, Natalia Alexeeva, Ryan Caldwell, Amol Soin
-
Patent number: 12370357Abstract: Cannula assemblies and methods of manufacturing cannula assemblies are provided. The cannula assembly includes a cannula and a pigtail extension coupled to the cannula. The pigtail extension includes a proximal section having a first stiffness and a distal section having a second stiffness, the first stiffness greater than the second stiffness. The proximal section of the pigtail extension is positioned between the cannula and at least a portion of the distal section.Type: GrantFiled: February 16, 2022Date of Patent: July 29, 2025Assignee: ABIOMED, Inc.Inventors: Scott C. Corbett, Caitlyn Hastie
-
Patent number: 12343545Abstract: A programmer is configured to effect communication with, and programming of, an implantable medical device configured to deliver neurostimulation therapy. The programmer comprises a display, such as touch screen display, and a processor comprising memory and coupled to the display. An interface is coupled to the processor and configured to receive therapy settings data indicative of current therapy settings operative in the implantable medical device and any modifications made to the therapy settings by a patient. The processor is configured to determine if one or more therapy settings have been modified since the last interaction with the patient, and coordinate displaying of the current therapy settings, the one or more therapy settings modified by the patient, and a previous state of the one or more therapy settings modified by the patient on the display.Type: GrantFiled: November 12, 2020Date of Patent: July 1, 2025Assignee: INSPIRE MEDICAL SYSTEMS, INC.Inventors: John Rondoni, Quan Ni
-
Patent number: 12343548Abstract: An AIMD includes a ceramic base closed with a ceramic lid, both cooperatively separating body fluid and device sides. The lid and circuit board both have active and conductive pathways. A circuit board has active and ground conductive pathways. An anisotropic conductive layer disposed between the lid device side and the circuit board has a first thickness where a first conductive particle is in electrical contact with the lid and the circuit board active conductive pathways electrically connected to the active terminal of an electronic component on the circuit board, a second thickness where a second conductive particle is in electrical contact with the lid and the circuit board ground conductive pathways electrically connected to the ground terminal of the electronic component. The anisotropic conductive layer has a third, greater thickness where no conductive particles are in electrical contact with the lid and circuit board conductive active and ground pathways.Type: GrantFiled: August 7, 2024Date of Patent: July 1, 2025Assignee: Greatbatch Ltd.Inventors: Robert A. Stevenson, Christine A Frysz, Keith W. Seitz, Brian P Hohl, Marc Gregory Martino
-
Patent number: 12343550Abstract: Current cancer treatments such as surgery, radiation and chemotherapy have significant side-effects for the patients. New treatments are being developed to reduce these side-effects while giving doctors alternative methods to treat patients. This invention introduces a new method for treatment of malignant tumors including brain cancer, pancreatic cancer, lung cancer, and ovarian cancer. The method uses low-power RF wave to disrupt and kill cancer cells during mitosis resulting in shrinking the size of solid tumors. Direction of polarization of the electric field of the RF wave relative to the axis of division of the cancer cells has an impact on the ability of the RF wave in disrupting mitosis and killing the cancer cells. Since the orientation of the cancer cells in a tumor are random a method is needed to change the orientation of the applied RF wave spatially with time to maximize elimination of the cancer cells.Type: GrantFiled: June 9, 2021Date of Patent: July 1, 2025Assignee: EVANESC THERAPEUTICS, INC.Inventors: Mehran Matloubian, Timothy J. Brockett, Gregg A. Hollingsworth
-
Patent number: 12311177Abstract: Apparatus and methods for managing pain uses a single composite modulation/stimulation signal with variable characteristics to achieve the same results as separate varying electromagnetic signals, including spinal cord stimulation or peripheral nerve stimulation.Type: GrantFiled: January 22, 2020Date of Patent: May 27, 2025Assignee: Medtronic SG, LLCInventors: Ricardo Vallejo, David Leonardo Cedeno, Nathan A. Torgerson, Brian Andrew Smith
-
Patent number: 12296159Abstract: A method of controlling operation of an implantable blood pump includes attempting to restart a stopped implantable blood pump for a predetermined number of attempts with either power from an internal battery of a controller in communication with the implantable blood pump or transcutaneous energy transfer system (TETS) power in communication with the internal battery and the implantable blood pump. Following the predetermined number of attempts, the method includes pausing attempting to restart the implantable blood pump and begin attempting to recharge the internal battery with TETS power.Type: GrantFiled: September 1, 2020Date of Patent: May 13, 2025Assignee: BOSTON SCIENTIFIC SCIMED, INC.Inventors: Eric A. Schilling, Joel B. Artmann, Jason C. Lee, David I. Siegfried
-
Patent number: 12296168Abstract: A hidden cochlear implant system comprises a canal unit and an implanted unit. The canal unit comprises at least one canal microphone; a canal modulator; a canal transmitting antenna: and a canal electrical power source, wherein the at least one canal microphone is electrically connected to the canal modulator, the canal modulator is electrically connected to the canal transmitting antenna, and the canal electrical power source is electrically connected to any component of the canal unit that requires supply of electrical power. The implanted unit comprises a cochlear receiving antenna; a processor; and an electrode array, wherein the cochlear receiving antenna is electrically connected to the processor, and the processor is electrically connected to the electrode array. Additional embodiments of the hidden cochlear implant are disclosed herein.Type: GrantFiled: June 4, 2021Date of Patent: May 13, 2025Assignee: Smart Sound LTD.Inventor: Harel Zilbershlag
-
Patent number: 12268881Abstract: A medical device comprises therapy delivery circuitry and processing circuitry. The therapy delivery circuitry is configured to deliver anti-tachycardia pacing (ATP) therapy to a heart of a patient. The ATP therapy includes one or more pulse trains and each of the one or more pulse trains includes a plurality of pacing pulses. The processing circuitry is configured to, for at least one of the plurality of pacing pulses of at least one of the one or more pulse trains, determine at least one latency metric of an evoked response of the heart to the pacing pulse. The processing circuitry is further configured to modify the ATP therapy based on the at least one latency metric.Type: GrantFiled: April 19, 2021Date of Patent: April 8, 2025Assignee: Medtronic, Inc.Inventors: Troy E. Jackson, Vincent P. Ganion
-
Patent number: 12246185Abstract: An apparatus configured to control transmission of wireless energy supplied to an electrically operable medical device adapted to be implanted in a mammal patient is provided.Type: GrantFiled: March 10, 2021Date of Patent: March 11, 2025Inventor: Peter Forsell
-
Patent number: 12220215Abstract: A physiological detection system including an image sensor, a converting unit, a retrieving unit and a processing unit is provided. The image sensor includes a plurality of pixels respectively configured to output a PPG signal. The converting unit is configured to convert a plurality of PPG signals of a plurality of pixels regions to a plurality of frequency domain signals. The retrieving unit is configured to respectively retrieve a spectral energy of the frequency domain signals corresponding to each of the pixel regions. The processing unit is configured to construct a 3D energy distribution according to the spectral energies.Type: GrantFiled: June 29, 2021Date of Patent: February 11, 2025Assignee: PIXART IMAGING INC.Inventors: Sen-Huang Huang, Ren-Hau Gu
-
Patent number: 12201822Abstract: A blood pump system includes a first implantable housing, an implantable blood pump independent from the first implantable housing, and a percutaneous extension. The first implantable housing includes a rechargeable power storage device. The implantable blood pump supplements the pumping function of a heart. The rechargeable power storage device supplies electrical power to the implantable blood pump. The percutaneous extension is coupled to the rechargeable power storage device and adapted to traverse the skin. The percutaneous extension is configured to releasably connect to an external power supply adapted to provide power for recharging or supplementing the rechargeable power storage device to power the implantable blood pump.Type: GrantFiled: September 22, 2020Date of Patent: January 21, 2025Assignee: TC1 LLCInventors: Charles Dague, Kevin Bourque
-
Patent number: 12171534Abstract: A physiological detection system including an image sensor, a converting unit, a retrieving unit and a processing unit is provided. The image sensor includes a plurality of pixels respectively configured to output a PPG signal. The converting unit is configured to convert a plurality of PPG signals of a plurality of pixels regions to a plurality of frequency domain signals. The retrieving unit is configured to respectively retrieve a spectral energy of the frequency domain signals corresponding to each of the pixel regions. The processing unit is configured to construct a 3D energy distribution according to the spectral energies.Type: GrantFiled: June 29, 2021Date of Patent: December 24, 2024Assignee: PIXART IMAGING INC.Inventors: Sen-Huang Huang, Ren-Hau Gu
-
Patent number: 12161475Abstract: An implantable medical device includes a memory storing criteria for transitioning between states of a cardiac cycle model, the states including a P-wave state. The device also includes sensing circuitry that senses a cardiac signal that varies as a function of a cardiac cycle of a patient, and also includes processing circuitry coupled to the sensing circuitry. The processing circuitry is configured to detect an R-wave in the sensed cardiac signal, to determine an elapsed time since the detection of the R-wave, to determine one or more morphological values of a post-R-wave segment of the cardiac signal to compare the elapsed time and the one or more morphological values to the stored criteria for transitioning between the plurality of states of the cardiac cycle model, and to detect a P-wave in the sensed cardiac signal in response to a transition to the P-wave state of the cardiac cycle model.Type: GrantFiled: June 24, 2020Date of Patent: December 10, 2024Assignee: Medtronic, Inc.Inventors: Michael T. Hemming, Saul E. Greenhut
-
Patent number: 12161853Abstract: An implantable medical device includes a functional unit, an introducer unit for introducing and/or navigating the functional unit in a lumen of body conduit(s) of a subject, and an elongated operable element connectable to a controller for operating the functional unit though the elongated operable element in a lumen of body conduit(s) of the subject. The functional unit, introducer unit, and elongated operable element may be in a slidable relationship for assembling and unassembling the implantable medical device in vivo. The implantable medical device is implantable, explantable, and operable in a lumen of body conduit(s) of a subject according to related methods.Type: GrantFiled: February 29, 2024Date of Patent: December 10, 2024Assignee: Puzzle Medical Devices Inc.Inventors: Yves-Antoine CrĂȘte, François Trudeau, Philippe Cormier, Maxime Rochon, Gabriel Georges, Dany Fillion
-
Patent number: 12070312Abstract: The disclosed system determines a fetal blood oxygenation level. During operation, the system activates two or more light sources, having different wavelengths, which are positioned on the abdomen of a pregnant mammal to direct light into the maternal abdomen toward a fetus. Next, the system receives a set of mixed signals from a set of photodetectors, which are positioned at different locations on the maternal abdomen to receive reflected light that traverses both maternal and fetal tissue. The system then performs a filtering operation that removes signal components associated with a maternal heart rate and a maternal respiration rate from the set of mixed signals to produce a set of fetal signals. Next, the system combines the set of fetal signals to produce a composite fetal signal. Finally, the system determines the fetal blood oxygenation level by performing a pulse-oximetry computation based on the composite fetal signal.Type: GrantFiled: March 16, 2020Date of Patent: August 27, 2024Assignee: The Regents of the University of CaliforniaInventors: Soheil Ghiasi, Daniel Fong
-
Patent number: 12064618Abstract: An oral care implement having conductive protrusions. In one embodiment, the oral care implement includes a handle and a head coupled to the handle. Furthermore, the oral care implement includes a power source. A plurality of conductive protrusions may be electrically coupled to the power source. The plurality of conductive protrusions may include a base proximate the head and a distal end spaced from the head. Furthermore, at least one of the conductive protrusions may taper from the base to the distal end.Type: GrantFiled: May 1, 2020Date of Patent: August 20, 2024Assignee: Colgate-Palmolive CompanyInventors: Patrik Johansson, Harsh Mahendra Trivedi, Douglas Hohlbein
-
Patent number: 12064639Abstract: A feedthrough for an AIMD includes a ferrule with an insulator hermetically sealing a ferrule opening, both cooperatively separating a body fluid side from a device side. A circuit board disposed adjacent to the insulator device side has a ground plate or ground trace electrically connected to a circuit board ground conductive pathway disposed in a circuit board ground via hole. An anisotropic conductive layer disposed between the circuit board and the insulator device side has an electrically insulative matrix supporting a plurality of electrically conductive particles. The anisotropic conductive layer has a first thickness where at least one first electrically conductive particle is longitudinally aligned and in electrical contact with the ferrule and the circuit board ground conductive pathway electrically connected to the at least one circuit board ground plate or ground trace.Type: GrantFiled: February 2, 2021Date of Patent: August 20, 2024Assignee: Greatbatch Ltd.Inventors: Robert A. Stevenson, Christine A. Frysz, Keith W. Seitz, Brian P Hohl, Marc Gregory Martino
-
Patent number: 12053258Abstract: Provided are a localization system and method useful in the acquisition and analysis of cardiac information. The localization system and method can be used with systems that perform cardiac mapping, diagnosis and treatment of cardiac abnormalities, as examples, and in the retrieval, processing, and interpretation of such types of information. The localization system and method use high impedance inputs, improved isolation, and relatively high drive currents for pairs of electrodes used to establish a multi-axis coordinate system. The axes can be rotated and scaled to improve localization.Type: GrantFiled: April 15, 2020Date of Patent: August 6, 2024Assignee: ACUTUS MEDICAL, INC.Inventors: Daniel J. Welsh, Marcus F. Julian, Graydon E. Beatty, Xinwei Shi, Derrick R. Chou, Randell L. Werneth, J. Christopher Flaherty, Mark MacGregor